Kopran Share Price
Start SIP in Kopran
Start SIPKopran Performance
Day Range
- Low 334
- High 353
52 Week Range
- Low 185
- High 370
- Open Price335
- Previous Close334
- Volume1650632
Kopran Investment Rating
-
Master Rating:
-
Kopran has an operating revenue of Rs. 637.03 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 11% is healthy, ROE of 10% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 19% and 27% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 14% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 88 which is a GOOD score indicating consistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 56 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 50 | 91 | 82 | 99 | 66 | 80 |
| Operating Expenses Qtr Cr | 44 | 75 | 70 | 90 | 64 | 73 |
| Operating Profit Qtr Cr | 5 | 15 | 12 | 9 | 2 | 7 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 1 | 2 | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 1 | 5 | 3 | 2 | 0 | 2 |
| Net Profit Qtr Cr | 4 | 15 | 9 | 11 | 0 | 6 |
Kopran Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹317.66
- 50 Day
- ₹292.01
- 100 Day
- ₹275.12
- 200 Day
- ₹258.18
- 20 Day
- ₹318.99
- 50 Day
- ₹281.63
- 100 Day
- ₹263.79
- 200 Day
- ₹261.81
Kopran Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 354.43 |
| Second Resistance | 362.92 |
| Third Resistance | 373.03 |
| RSI | 67.76 |
| MFI | 71.79 |
| MACD Single Line | 16.64 |
| MACD | 18.17 |
| Support | |
|---|---|
| First Support | 335.83 |
| Second Support | 325.72 |
| Third Supoort | 317.23 |
Kopran Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,720,045 | 60,046,771 | 34.91 |
| Week | 2,332,667 | 73,852,237 | 31.66 |
| 1 Month | 2,021,367 | 63,086,869 | 31.21 |
| 6 Month | 760,526 | 28,398,038 | 37.34 |
Kopran Result Highlights
Kopran Synopsis
NSE-Medical-Diversified
Kopran Ltd is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 337.46 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2024. Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078.| Market Cap | 1,668 |
| Sales | 321 |
| Shares in Float | 2.70 |
| No of funds | 32 |
| Yield | 0.87 |
| Book Value | 4 |
| U/D Vol ratio | 2.4 |
| LTDebt / Equity | 1 |
| Alpha | 0.02 |
| Beta | 1.54 |
Kopran Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 44.49% | 44.49% | 44.49% | 44.49% |
| Mutual Funds | 0.94% | 0.21% | ||
| Insurance Companies | 0.13% | 0.14% | 0.14% | 0.14% |
| Foreign Portfolio Investors | 0.68% | 0.84% | 0.48% | 0.39% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 39.68% | 37.98% | 39.9% | 40.45% |
| Others | 15.02% | 15.61% | 14.99% | 14.32% |
Kopran Management
| Name | Designation |
|---|---|
| Mr. Susheel G Somani | Chairman |
| Mr. Surendra Somani | Executive Vice Chairman |
| Mr. Adarsh Somani | Director |
| Mr. Varun Somani | Director |
| Dr. Siddhan Subramanian | Independent Director |
| Dr. Sunita Banerji | Independent Director |
| Mrs. Mamta Biyani | Independent Director |
| Mr. Narayan Atal | Independent Director |
Kopran Forecast
Price Estimates
Kopran Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-08 | Quarterly Results | |
| 2024-05-16 | Audited Results & Final Dividend | |
| 2024-02-07 | Quarterly Results | |
| 2023-11-07 | Quarterly Results | |
| 2023-08-10 | Quarterly Results |
Kopran FAQs
What is Share Price of Kopran ?
Kopran share price is ₹345 As on 15 September, 2024 | 19:04
What is the Market Cap of Kopran ?
The Market Cap of Kopran is ₹1667.8 Cr As on 15 September, 2024 | 19:04
What is the P/E ratio of Kopran ?
The P/E ratio of Kopran is 28.1 As on 15 September, 2024 | 19:04
What is the PB ratio of Kopran ?
The PB ratio of Kopran is 3.4 As on 15 September, 2024 | 19:04